Cheelcare Inc. (TSXV: CHER | OTC: CHCRF), a Markham, Ontario-based developer of advanced mobility solutions, has announced the grant of 485,000 incentive stock options effective November 13, 2026. The options are exercisable at $1.50 per common share and expire on November 13, 2031. The announcement also confirmed board committee leadership following the company's Annual General Meeting held on the same date, with existing chairs continuing in their roles.

Key Points

  • Cheelcare Inc. (TSXV: CHER | OTC: CHCRF) is a Canadian innovator in advanced mobility solutions.
  • The company granted an aggregate of 485,000 incentive stock options to directors, officers, employees, and consultants, effective November 13, 2026.
  • Options are exercisable at $1.50 per common share until November 13, 2031, with vesting schedules varying by recipient group.
  • Investors may be watching for TSX Venture Exchange acceptance of the option grant where required under applicable policies.

Vesting Structure Across Cheelcare's Option Recipients

Of the 485,000 options granted, 220,000 were allocated to directors and 25,000 to a consultant — both groups vesting in full on the first anniversary of the November 13, 2026 grant date. The remaining 240,000 options, comprising 220,000 to employees and 20,000 to a separate consultant, follow a two-year schedule: 50% vest on the first anniversary and the remaining 50% on the second anniversary. All options are subject to the terms of the company's stock option plan and applicable TSX Venture Exchange policies, including exchange acceptance where required.

Board Committee Continuity After Cheelcare's 2026 Annual General Meeting

Following its Annual General Meeting on November 13, 2026, Cheelcare's Board of Directors confirmed the continuation of its existing committees and their chairs. Trevor Treweeke will remain Chair of the Audit Committee, while Marc Kazimirski continues as Chair of the Governance, Human Resources, Nominating and Compensation Committee. Roy Ellis will continue to serve as Chairman of the Board. The company did not disclose any changes to overall board composition in connection with this announcement.

Cheelcare's Mobility Solutions Business and Product Focus

Cheelcare designs and manufactures mobility solutions aimed at supporting independence for people with disabilities. The company's product portfolio includes power assist devices and the Curio robotic complex-rehab power wheelchair. The stock option grant is a common compensation mechanism used by TSX Venture Exchange-listed companies to align the interests of key personnel with those of shareholders. The immediate share price impact of this announcement was not clear from available public information.